Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.85 TWD
375.17 M TWD
2.96 B TWD
164.49 M
About SINPHAR PHARMACEUTICAL CO LTD
Sector
CEO
Yu-Liang Pei
Headquarters
I-lan
Website
Founded
1977
ISIN
TW0001734002
FIGI
BBG000F89247
Sinphar Pharmaceutical Co. Ltd. engages in the production, processing, and trading of medicines, Chinese medicines, medical cosmetic products, and nutrients. It operates through the following segments: Pharmaceutical, Healthy Food, and Others. The company was founded on July 2, 1977 and is headquartered in I-lan, Taiwan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1734 is 30.60 TWD — it has increased by 0.16% in the past 24 hours. Watch SINPHAR PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange SINPHAR PHARMACEUTICAL CO LTD stocks are traded under the ticker 1734.
1734 stock has risen by 4.05% compared to the previous week, the month change is a 0.49% rise, over the last year SINPHAR PHARMACEUTICAL CO LTD has showed a −2.37% decrease.
We've gathered analysts' opinions on SINPHAR PHARMACEUTICAL CO LTD future price: according to them, 1734 price has a max estimate of 31.00 TWD and a min estimate of 31.00 TWD. Watch 1734 chart and read a more detailed SINPHAR PHARMACEUTICAL CO LTD stock forecast: see what analysts think of SINPHAR PHARMACEUTICAL CO LTD and suggest that you do with its stocks.
1734 reached its all-time high on Jul 13, 2020 with the price of 63.45 TWD, and its all-time low was 12.10 TWD and was reached on Jul 18, 2006. View more price dynamics on 1734 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1734 stock is 1.32% volatile and has beta coefficient of 0.25. Track SINPHAR PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is SINPHAR PHARMACEUTICAL CO LTD there?
Today SINPHAR PHARMACEUTICAL CO LTD has the market capitalization of 5.57 B, it has increased by 1.03% over the last week.
Yes, you can track SINPHAR PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
SINPHAR PHARMACEUTICAL CO LTD is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
1734 net income for the last quarter is 47.63 M TWD, while the quarter before that showed 64.94 M TWD of net income which accounts for −26.66% change. Track more SINPHAR PHARMACEUTICAL CO LTD financial stats to get the full picture.
Yes, 1734 dividends are paid annually. The last dividend per share was 1.00 TWD. As of today, Dividend Yield (TTM)% is 3.01%. Tracking SINPHAR PHARMACEUTICAL CO LTD dividends might help you take more informed decisions.
SINPHAR PHARMACEUTICAL CO LTD dividend yield was 2.95% in 2023, and payout ratio reached 44.70%. The year before the numbers were 3.02% and 74.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINPHAR PHARMACEUTICAL CO LTD EBITDA is 574.62 M TWD, and current EBITDA margin is 17.87%. See more stats in SINPHAR PHARMACEUTICAL CO LTD financial statements.
Like other stocks, 1734 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINPHAR PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SINPHAR PHARMACEUTICAL CO LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SINPHAR PHARMACEUTICAL CO LTD stock shows the neutral signal. See more of SINPHAR PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.